Remi Gaston-dreyfus - Net Worth and Insider Trading
Remi Gaston-dreyfus Net Worth
The estimated net worth of Remi Gaston-dreyfus is at least $19 dollars as of 2024-12-01. Remi Gaston-dreyfus is the Director, 10% Owner of Bionik Laboratories Corp and owns about 1,876,127 shares of Bionik Laboratories Corp (BNKL) stock worth over $19. Details can be seen in Remi Gaston-dreyfus's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Remi Gaston-dreyfus has not made any transactions after 2023-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Remi Gaston-dreyfus
Remi Gaston-dreyfus Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Remi Gaston-dreyfus owns 1 companies in total, including Bionik Laboratories Corp (BNKL) .
Click here to see the complete history of Remi Gaston-dreyfus’s form 4 insider trades.
Insider Ownership Summary of Remi Gaston-dreyfus
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BNKL | Bionik Laboratories Corp | 2023-06-09 | director & 10 percent owner |
Remi Gaston-dreyfus Latest Holdings Summary
Remi Gaston-dreyfus currently owns a total of 1 stock. Remi Gaston-dreyfus owns 1,876,127 shares of Bionik Laboratories Corp (BNKL) as of June 9, 2023, with a value of $19.
Latest Holdings of Remi Gaston-dreyfus
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BNKL | Bionik Laboratories Corp | 2023-06-09 | 1,876,127 | 0.00 | 19 |
Holding Weightings of Remi Gaston-dreyfus
Remi Gaston-dreyfus Form 4 Trading Tracker
According to the SEC Form 4 filings, Remi Gaston-dreyfus has made a total of 1 transactions in Bionik Laboratories Corp (BNKL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Bionik Laboratories Corp is the acquisition of 180,555 shares on June 9, 2023, which cost Remi Gaston-dreyfus around $108,333.
Insider Trading History of Remi Gaston-dreyfus
- 1
Remi Gaston-dreyfus Trading Performance
GuruFocus tracks the stock performance after each of Remi Gaston-dreyfus's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Remi Gaston-dreyfus is -47.24%. GuruFocus also compares Remi Gaston-dreyfus's trading performance to market benchmark return within the same time period. The performance of stocks bought by Remi Gaston-dreyfus within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Remi Gaston-dreyfus's insider trading performs compared to the benchmark.
Performance of Remi Gaston-dreyfus
Remi Gaston-dreyfus Ownership Network
Remi Gaston-dreyfus Owned Company Details
What does Bionik Laboratories Corp do?
Who are the key executives at Bionik Laboratories Corp?
Remi Gaston-dreyfus is the director & 10 percent owner of Bionik Laboratories Corp. Other key executives at Bionik Laboratories Corp include director & Chairman Andre-jacques Auberton-herve , Executive Vice President & CFO Daniel Gonsalves , and See Remarks Loren W. Wass .
Bionik Laboratories Corp (BNKL) Insider Trades Summary
Over the past 18 months, Remi Gaston-dreyfus made 1 insider transaction in Bionik Laboratories Corp (BNKL) with a net purchase of 180,555. Other recent insider transactions involving Bionik Laboratories Corp (BNKL) include a net purchase of 650,000 shares made by Andre-jacques Auberton-herve , a net purchase of 180,555 shares made by Charles Matine ,
In summary, during the past 3 months, insiders sold 0 shares of Bionik Laboratories Corp (BNKL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bionik Laboratories Corp (BNKL) were sold and 1,011,110 shares were bought by its insiders, resulting in a net purchase of 1,011,110 shares.
Bionik Laboratories Corp (BNKL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bionik Laboratories Corp Insider Transactions
Remi Gaston-dreyfus Mailing Address
Above is the net worth, insider trading, and ownership report for Remi Gaston-dreyfus. You might contact Remi Gaston-dreyfus via mailing address: 46 Rue Pierre Charron, Paris I0 75008.